World Diabetes Day, observed on Nov 14 each year, seeks to raise global awareness and improve outcomes for the 537 million people estimated to be living with diabetes around the world and those with, as yet, undiagnosed diabetes. Recognising that diabetes affects mental health as much as physical health, 2024 marks the start of a 3-year campaign focusing on diabetes and wellbeing, which aims to prioritise wellbeing support in diabetes care.
Migrants have unique risk factors for under-immunisation in the MENA region and have low vaccination coverage despite some level of entitlement to services. Data on…
The diagnosis and management of adrenal insufficiency presents major clinical challenges. Of concern, adrenal insufficiency-related hospital admissions and adrenal crises (with their associated morbidity and…
Euro 120,000 available for four Fellowships The EASD Rising Star Symposium and EFSD Rising Star Fellowship Programme aims to identify promising and innovative young researchers…
Synthetic data, generated through artificial intelligence technologies such as generative adversarial networks and latent diffusion models, maintain aggregate patterns and relationships present in the real…
Descriptive epidemiology is important for understanding causes, evaluating potential effects of policies and environmental changes, and anticipating needs for prevention and care. Adolescence and young…
There is variability in the trajectory of the incidence of young-adult-onset type 2 diabetes among high-income countries or jurisdictions, with a greater evidence of increase…
Younger-onset type 2 diabetes is rapidly increasing in prevalence, with the majority presenting in adulthood aged 18–39 years.1 This change in diabetes topography presents a…
The risk of dying relative to the general population is even greater for people diagnosed with type 2 diabetes at younger ages. The increased risk…
Lomitapide provided a significant, clinically meaningful LDL cholesterol reduction and has the potential to be an efficient, LDL receptor-independent option for paediatric patients with HoFH.
Homozygous familial hypercholesterolaemia (HoFH), a rare condition that affects about one in 300 000 individuals worldwide, is among the most challenging dyslipidaemias to treat.1 The underlying…
